Tuesday, December 03, 2019 11:03:23 AM
There are a zillion stop smoking/quit dipping aids currently. They’ve got gum, lozenges, pouches for dippers, etc already on the market. Market share will be an enormous battle and CVSI MS is already dwindling.
So people will buy pluscbd for daily use and also buy pluscbd nicotine gum (which will, without a doubt, be more expensive)?
Maybe I just don’t get the angle. Are they banking on millions of people switching because there’s a dash of cbd in the gum? Seems a stretch imo.
Personally, I think the pharma division is a bit of a joke thus far.
Perhaps to tickle the fancy of retail investors.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM